Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Argininosuccinate synthetase 1 pseudogene 12 (ASS1P12)** is a human pseudogene; it is a non-functional DNA segment related by sequence to the protein-coding gene *ASS1* (argininosuccinate synthase 1), but does not encode a functional protein. As a pseudogene, ASS1P12 is not known to have any molecular function, biological role, disease association, or relevance as a therapeutic target. It exists as part of the genome because gene duplications and related processes have produced multiple pseudogenic copies of the functional *ASS1* gene, and these are common in the human genome[3][4][6]. **Key clarification**: ASS1P12 should not be confused with the functional *argininosuccinate synthase 1* enzyme encoded by *ASS1*, which is biologically active in the urea cycle and clinically relevant, especially regarding citrullinemia and cancer metabolism[1][2]. ASS1P12, as a pseudogene, is currently not known to have any biological or therapeutic significance and is not a druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate synthetase 1 pseudogene 12 (ASS1P12).